الفرق بين المراجعتين لصفحة: «قالب:عوامل العلاج الكيميائي خارج الخلوية»

من موسوعة العلوم العربية
اذهب إلى التنقل اذهب إلى البحث
(نقل مع رابط للقالب الإنكليزي)
 
 
(5 مراجعات متوسطة بواسطة مستخدمين اثنين آخرين غير معروضة)
سطر 1: سطر 1:
{{Navbox
{{Navbox
| name  = Extracellular chemotherapeutic agents
| name  = Extracellular chemotherapeutic agents
| title = [[معالجة مستهدفة]]
| title = [[Targeted therapy]] / extracellular [[Chemotherapy (oncology)|chemotherapeutic agents]]/[[Antineoplastic|antineoplastic agents]] ([[ATC code L01|L01]])
<br />
| state = {{{state|autocollapse}}}
[[Targeted therapy]] / extracellular [[Chemotherapy (oncology)|chemotherapeutic agents]]/[[Antineoplastic|antineoplastic agents]] [[ATC code L01|L01]] <br />
[http://en.wikipedia.org/wiki/Template:Extracellular_chemotherapeutic_agents القالب الإنكليزي]
|listclass = hlist
|listclass = hlist
| groupstyle = background-color: #E5BFE5
| groupstyle = background-color: #E5BFE5
سطر 17: سطر 15:
* [[ErbB]]: ''[[Epidermal growth factor receptor|HER1/EGFR]]'' ([[Cetuximab]]
* [[ErbB]]: ''[[Epidermal growth factor receptor|HER1/EGFR]]'' ([[Cetuximab]]
* [[Panitumumab]])
* [[Panitumumab]])
* ''[[HER2/neu]]'' ([[Trastuzumab]])
* ''[[HER2/neu]]'' ([[Trastuzumab]]
* [[Trastuzumab emtansine]])


| group2 = Others for solid tumors
| group2 = Others for solid tumors
سطر 50: سطر 49:


* [[RTK class III]]: ''[[CD117|C-kit]] and [[Platelet-derived growth factor receptor|PDGFR]]'' ([[Axitinib]]
* [[RTK class III]]: ''[[CD117|C-kit]] and [[Platelet-derived growth factor receptor|PDGFR]]'' ([[Axitinib]]
* [[Masitinib]]
* [[Pazopanib]]
* [[Pazopanib]]
* [[Sunitinib]]
* [[Sunitinib]]
سطر 68: سطر 68:
| group2 = [[Non-receptor tyrosine kinase|Non-receptor]]
| group2 = [[Non-receptor tyrosine kinase|Non-receptor]]
| list2  =
| list2  =
* ''[[Bcr-abl fusion protein|bcr-abl]]'' ([[Dasatinib]]
* ''[[Bcr-abl fusion protein|bcr-abl]]'' ([[Imatinib]]
* [[Imatinib]]
* [[Dasatinib]]
* [[Nilotinib]])
* [[Nilotinib]]
* [[Ponatinib]])


*''[[Src (gene)|Src]]'' ([[Bosutinib]])
*''[[Src (gene)|Src]]'' ([[Bosutinib]])
سطر 79: سطر 80:
''[[EML4]]-[[Anaplastic lymphoma kinase|ALK]]'' ([[Crizotinib]])
''[[EML4]]-[[Anaplastic lymphoma kinase|ALK]]'' ([[Crizotinib]])


RET inhibitors: Vandetanib (Also VEGFR and EGFR).
''RET inhibitors:'' [[Vandetanib]] (Also VEGFR and EGFR).
c-MET inhibitor: Cabozantinib (Also VEGFR2).
''c-MET inhibitor:'' [[Cabozantinib]] (Also VEGFR2).
}}
}}


   | group4 = أخرى
   | group4 = Other
   |  list4 =
   |  list4 =
* ''[[fusion protein]] against [[Vascular endothelial growth factor|VEGF]]'' ([[Aflibercept]])
* ''[[fusion protein]] against [[Vascular endothelial growth factor|VEGF]]'' ([[Aflibercept]])
سطر 90: سطر 91:
* ''[[mTOR inhibitor]]s'' ([[Everolimus]]
* ''[[mTOR inhibitor]]s'' ([[Everolimus]]
* [[Temsirolimus]])
* [[Temsirolimus]])
| belowstyle = background: transparent; padding: 0px;
| below = {{Neoplasia navs}}


}}<noinclude>
}}<noinclude>
[[Category:Antineoplastic drugs]]
[[Category:Drug_templates by ATC]]
[[Category:Oncology templates]]
[[تصنيف:جداول تصفح الأدوية]]
[[تصنيف:جداول تصفح الأدوية]]
</noinclude>
</noinclude>

المراجعة الحالية بتاريخ 16:30، 8 أغسطس 2013